Looking to publish in Respiratory Medicine And Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowRespiratory Medicine and Research is the peer-reviewed English-language e-only journal of the French Society of Respiratory Diseases (SPLF). It publishes research articles, review articles, guidelines, and consensus statements across all areas of respiratory diseases with an international scope.
Looking to publish in Respiratory Medicine And Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Respiratory Medicine And Research accepts the following article types. Click on an article type to view submission instructions.
Research Paper
Original Article
Review Article
Short Communication
Letters To Editors
Recommendations
Guidelines
Consensus
Correspondence
Recent Publications
Pulmonary sarcoïdosis presenting as acute hypoxemic respiratory failure
Jérémie Hestin, Sadek Mortada, Dominique Valeyre, Jean-Luc Jagot, Jean-Marc Naccache
Feasibility of an innovative follow-up method alternating face-to-face consultations and teleconsultations for adult patients with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor (ETI) for at least one year
Vidal Thomas, Durieu Isabelle, Perceval Marie, Reis-de-castro Rachel, Richard Mael, Roubertou Yoann, Reynaud Quitterie
Assessment of the interobserver reliability in discharge decision-making for patients undergoing thoracic surgery based on chest ultrasound compared to chest X-ray findings
Zaineb Guesmi, Martin Faure, Julia Ballouhey, Lina Atlagh, François Bertin, Anaelle Chermat, Caroline Rivera, François Vincent, Benoit Aguado, Jérémy Tricard
Prognostic value of metabolic activity in noncancerous lung areas for stage I lung cancer
Takashi Yamamichi, Yoshihisa Shimada, Hideyuki Furumoto, Yujin Kudo, Masaru Hagiwara, Masatoshi Kakihana, Tatsuo Ohira, Norihiko Ikeda
Chalazion and hordeolum associated with Elexacaftor-Tezacaftor-Ivacaftor use in children with cystic fibrosis
Christy Liew, Andrew Brookes, Emma L Guy, Lee Wisby, Sarah J Mayell, Laura C Walker, Tim WR Lee
Frequently asked questions
How long does it take to publish?
77 days from submission to decision after review; 175 days from submission to acceptance; 6 days from acceptance to first online publication.
Reformat to Respiratory Medicine And Research using Livewrite PremiumIs a cover letter required?
A letter to the Editor-in-Chief must accompany the manuscript if the manuscript contains more authors than the recommendations for the article category.
Reformat to Respiratory Medicine And Research using Livewrite PremiumWhat are the publication costs?
Article publishing charge (APC) applies for open access articles if the manuscript is accepted.
Reformat to Respiratory Medicine And Research using Livewrite Premium